Human OGN adenoviral particles

The osteoglycin (OGN) gene, also known as mimecan, encodes a leucine-rich small proteoglycan (SLRP) that plays a key role in the organization and tissue homeostasis of the extracellular matrix (ECM). OGN is widely expressed in connective tissues, including bone, cartilage, and cornea, and is involved in collagen fibrillogenesis and the structural integrity of the ECM. Studies have shown that OGN is involved in regulating cell proliferation, adhesion, and differentiation, and is associated with wound healing, fibrosis, and metabolic disorders. In addition, OGN has been associated with cardiovascular disease and cancer progression, highlighting its multifaceted biological functions. Due to its regulatory role, OGN has become a promising target for gene therapy and biomedical research, and efficient delivery tools such as adenoviral vectors are needed to explore its therapeutic potential.

Human OGN adenoviral particles are a replication-defective viral vector designed to efficiently deliver the OGN gene to mammalian cells. These particles exploit the natural infectivity of adenoviruses and exhibit broad tropism and strong transgene expression, making them ideal for in vitro and in vivo applications. The adenoviral backbone has been modified to remove essential viral genes to ensure safety, while placing the OGN under the control of a strong promoter to drive high-level expression. These particles are particularly important for studying the functional mechanisms of OGNs because they enable rapid and sustained gene delivery in a variety of cell types, including primary cells and difficult-to-transfect cell lines.